TEST 4: Obesity Flashcards
Obesity overview
Definition
Criteria
Kids
(Lecture, p. 723)
-A metabolic disorder that develops when calorie intake exceeds energy expenditure over time in genetically susceptible individuals
-In adults, obesity= BMI > 30
-Class 1: BMI 30 to 34
-Class 2: BMI 35 to 39
-Class 3: BMI > 40 “severe”
-In kids:
-BMI > 95th percentile for age and gender
—120% of 95% peregrine or greater OR 35 kg/m2 or greater
Adipose tissue
What is it?
What are the types (4)
(P. 723)
-Provides insulation and mechanical support
-Body’s major energy reserve to fuel other tissues
4 types:
-White
-Brown
-Beige
-Bone marrow
GEM- MOST fat in the body is white
White adipose tissue (WAT)
What is it?
Where is it?
What does it do?
(P. 723, AO)
-Comprises the majority of adipose tissue in the body
-Located in visceral (central) and subcutaneous (peripheral) stores
-Contributes to the regulation of energy homeostasis:
-Crucial for storing excess energy in the form of triglycerides and releasing that energy when needed
-in excess, contributes to obesity and metabolic disorders (increases insulin resistance and inflammation)
Adipokines deregulated vs.
Adipocytes regulated
726-727
Adipokines:
Leptin, adiponectin, resistin, RBP-4 when deregulated:
-HTN, CVA. Obesity, DM, Arthritis, metabolic syndrome, NASH
Adipocytes when regulated (a million types listed):
-Appetite, satiety, insulin sensitivity, fat distribution, energy, blood pressure, metabolic health
White adipose tissue
Contribution in times of excess
(P.723)
When the energy balance is positive, excess fat is stored in white Adipocytes:
-Cells hypertrophy and become hyperplastic
-Causes dysregulation of adipokines—> pro inflammatory state and altered lipid metabolism—> contributes to obesity comorbidities
Altered Adipocytes—> insulin resistance (lipolysis and release Of FFA)—> macrophage infiltration (TNF-alpha and IL-6)
Appetite and satiety control
Where in the brain?
Neuron types?
Peptides?
(AO, slides)
-Controlled by arcuate nucleus in the hypothalamus (responsible for balancing metabolism)
-Arcuate nucleus has 2 types of cells:
1. Orexogenic neurons: stimulate appetite decrease metabolism
2. Anorexic neurons: suppress appetite and increase metabolism
Orexins= neuro peptides that stimulate appetite
Anorexins = neuro peptides that inhibit appetite
Orexins
(P. 727)
Ghrelin:
-Produced in the stomach in response to hunger
-Ghrelin receptors in hypothalamus—> growth hormone that—> release gastric acid, increases GI motility, pancreatic secretion of insulin
-Lean people: elevate with hunger and fall after eating
-In obesity: levels remain elevated after eating (increased body weight and fat mass)
Endocannabinoids:
-Produced in the brain and peripheral nerves
-Increases appetite, nutrient absorption and lipogenesis
-Increases peripheral and central adipose tissue accumulation
Anorexins
(P.726)
Leptin:
-Produced by Adipocytes, acts on hypothalamus
-Decreases appetite and energy expenditure
-As Adipocytes increase, Leptin secretion increases
High levels of Leptin lose effectiveness (Leptin resistance) —> disrupts hypothalamus signals of satiety—> overeat—> increased weight
Glucagon-like Peptide-I :
-Stimulates pancreatic glucose dependent insulin secretion
-Decreases gastric emptying—> decreased appetite and increased satiety
Adiponectin
(P. 726)
-An Anorexin, increases energy expenditure
-Has insulin sensitizing and anti inflammatory properties
-Levels will decrease in obesity—> increased insulin resistance, increased CAD risk, and increased inflammatory markers.
Shifts in obesity from normal
Hunger
Ghrelin and endocannabinoid—> does NOT decrease after eating, so you lose the feedback loop to stop hunger (increases appetite)
Leptin, GLP-I, adiponectin—> levels are high but there is resistance, so you lose the signal to stop eating, lose the satiety sensor, and lose protective properties
Apple vs pear shape obesity
Apple:
-VISCERAL obesity: accelerated lipolysis, increased inflammation and metabolic syndromes
-Associated with HIGHER risks of obesity related health issues (of more concern)
Pear:
-PERIPHERAL obesity: fat is less metabolically active, releases fewer adipocytokines—> risk of obesity is less severe
-Associated with lower obesity related health complications (of less concern)
Obesity as multi-system syndrome
-Chronic complications are associated with > 200 health conditions
-Underlying etiologies: chronic inflammation, metabolic disorders, increased free fatty acids
Cardiovascular: Atherosclerosis, HTN, CAD, HF, renal disease, CVA
Cancer: Breast, colon, renal, stomach, pancreatic, liver, ovarian/ endometrial
GI: GERD, gallstones, fatty liver
Pulmonary: Sleep apnea, asthma exercise intolerance
Musculoskeletal: osteoarthritis, back pain, plantar fasciitis
Endocrine: insulin resistance, type 2 DM,
Infertility
Obesity treatment
-Is a chronic, relapsing disease
Treatment focus areas:
-Address metabolic abnormalities
-Lifestyle change
-CBT/ support groups
-GLP-I and GIP receptors agonists
-Bariatric surgery (Gastric bypass, roux-en-Y, gastric banding, gastric sleeve)
Leptin
(AO)
-Hormone Produced by adipose tissue
-Signals the hypothalamus to suppress appetite and stimulate energy expenditure
-In obesity, elevated leptin levels can lead to leptin resistance so its effectiveness is reduced and hunger is not suppressed (ie you always feel hungry)
-DECREASE APPETITE
Ghrelin
(AO)
-Hormone secreted by the stomach
-Known as “hunger hormone”
-Stimulates appetite and promotes food intake
-Ghrelin levels rise before meals and fall after
-In obesity, patterns are altered and Ghrelin’s suppressive effect on hunger is reduced
-INCREASE APPETITE